By DAVID BARBOZA
Vivian Shi, whom GlaxoSmithKline investigated over making allegations of fraud and corruption in China, has rejoined the company.
Published: August 5, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1SYYRBy
from WordPress http://ift.tt/1IJzxy4
via Hadi Aboukhater
No comments:
Post a Comment